Variability in Proteinase-antiproteinase Balance, Nutritional Status, and Quality of Life in Stable Chronic Obstructive Pulmonary Disease Due to Tobacco and Nontobacco Etiology
Overview
Authors
Affiliations
Context: Although the role of proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease (COPD) due to tobacco is well established, information in COPD due to nontobacco etiology is sparse.
Aims: To assess the variability in metalloproteinase activity in COPD related to tobacco and nontobacco causes.
Settings And Design: This is a hospital-based, prospective, observational study.
Subjects And Methods: Serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) were estimated in 200 subjects divided equally into four groups, i.e. COPD in tobacco smokers, COPD in nonsmokers but with exposure to biomass-related indoor air pollution, smokers without COPD, and nonsmoking healthy controls. Anthropometric skinfold measurements, quality of life (QOL) using St. George Respiratory Questionnaire, and exercise capacity using the 6-min walk test (6-MWT) were carried out. Groups were compared using analysis of variance and Kruskal-Wallis plus Mann-Whitney U-test to assess differences between groups. The Chi-square and Fisher's exact tests were used to evaluate associations among categorical variables. Spearman's rank correlation was calculated to assess the correlation between data.
Results: Patients with COPD due to either tobacco or nontobacco etiology were older, more malnourished, had worse QOL, and poorer exercise capacity compared to non-COPD subjects. Triceps, subscapular, and suprailiac skinfold thicknesses were less in smokers with COPD than biomass-related COPD. MMP-9 and TIMP-1 levels were similar across all groups. TIMP-1 significantly correlated with 6-MWT among all groups.
Conclusions: The protease-antiprotease balance in COPD is similar irrespective of the presence or absence of tobacco exposure but is related to poor exercise capacity.
MicroRNA Let-7 Induces M2 Macrophage Polarization in COPD Emphysema Through the IL-6/STAT3 Pathway.
Liu T, Zhang Z, Shen W, Wu Y, Bian T Int J Chron Obstruct Pulmon Dis. 2023; 18:575-591.
PMID: 37077365 PMC: 10108876. DOI: 10.2147/COPD.S404850.
Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD Regulating DNMT1.
Zhang F, Guo F, Liu Y, Zhang Y, Li D, Yang H Front Pharmacol. 2022; 13:903593.
PMID: 35754478 PMC: 9214040. DOI: 10.3389/fphar.2022.903593.
Nonsmoker COPD: Is it a reality?.
Sharma B, Singh V Lung India. 2017; 34(2):117-119.
PMID: 28360456 PMC: 5351350. DOI: 10.4103/lungindia.lungindia_56_17.